This document is page 16 of a Cannabis Investment Report produced by Ackrell Capital in December 2017. It provides a biological overview of cannabis, detailing the differences between Sativa, Indica, and Ruderalis leaves, and explaining chemical compounds such as cannabinoids (THC, CBD) and terpenes. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was obtained as part of a congressional investigation, likely related to inquiries into Jeffrey Epstein's finances or investments, though no specific individuals are named on this page.
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC |
Header and footer indicate this is their report.
|
|
| FINRA |
Ackrell Capital is listed as a member.
|
|
| SIPC |
Ackrell Capital is listed as a member.
|
|
| House Oversight Committee |
Implied by Bates stamp 'HOUSE_OVERSIGHT_024652'.
|
"Many hybrid varieties of cannabis—sometimes referred to as strains—have developed from these three species, both through selective breeding and in the wild."Source
"The primary cannabinoid in most cannabis is tetrahydrocannabinol, or THC, the psychoactive compound responsible for the “high” or euphoric feeling commonly associated with cannabis consumption."Source
Complete text extracted from the document (2,399 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document